These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 34154611)
21. Whole exome sequencing reveals intertumor heterogeneity and distinct genetic origins of sporadic synchronous colorectal cancer. Di J; Yang H; Jiang B; Wang Z; Ji J; Su X Int J Cancer; 2018 Mar; 142(5):927-939. PubMed ID: 29105743 [TBL] [Abstract][Full Text] [Related]
22. Organoid cultures of early-onset colorectal cancers reveal distinct and rare genetic profiles. Yan HHN; Siu HC; Ho SL; Yue SSK; Gao Y; Tsui WY; Chan D; Chan AS; Wong JWH; Man AHY; Lee BCH; Chan ASY; Chan AKW; Hui HS; Cheung AKL; Law WL; Lo OSH; Yuen ST; Clevers H; Leung SY Gut; 2020 Dec; 69(12):2165-2179. PubMed ID: 32217638 [TBL] [Abstract][Full Text] [Related]
23. Multifocal Organoid Capturing of Colon Cancer Reveals Pervasive Intratumoral Heterogenous Drug Responses. Kim SC; Park JW; Seo HY; Kim M; Park JH; Kim GH; Lee JO; Shin YK; Bae JM; Koo BK; Jeong SY; Ku JL Adv Sci (Weinh); 2022 Feb; 9(5):e2103360. PubMed ID: 34918496 [TBL] [Abstract][Full Text] [Related]
24. PTEN phosphatase-independent maintenance of glandular morphology in a predictive colorectal cancer model system. Jagan IC; Deevi RK; Fatehullah A; Topley R; Eves J; Stevenson M; Loughrey M; Arthur K; Campbell FC Neoplasia; 2013 Nov; 15(11):1218-30. PubMed ID: 24348097 [TBL] [Abstract][Full Text] [Related]
25. Grouped-seq for integrated phenotypic and transcriptomic screening of patient-derived tumor organoids. Wu Y; Li K; Li Y; Sun T; Liu C; Dong C; Zhao T; Tang D; Chen X; Chen X; Liu P Nucleic Acids Res; 2022 Mar; 50(5):e28. PubMed ID: 34893868 [TBL] [Abstract][Full Text] [Related]
26. Modeling tumor development and metastasis using paired organoids derived from patients with colorectal cancer liver metastases. Li H; Dai W; Xia X; Wang R; Zhao J; Han L; Mo S; Xiang W; Du L; Zhu G; Xie J; Yu J; Liu N; Huang M; Zhu J; Cai G J Hematol Oncol; 2020 Sep; 13(1):119. PubMed ID: 32883331 [TBL] [Abstract][Full Text] [Related]
27. Development of a system combining comprehensive genotyping and organoid cultures for identifying and testing genotype-oriented personalised medicine for pancreatobiliary cancers. Shiihara M; Ishikawa T; Saiki Y; Omori Y; Hirose K; Fukushige S; Ikari N; Higuchi R; Yamamoto M; Morikawa T; Nakagawa K; Hayashi H; Mizuma M; Ohtsuka H; Motoi F; Unno M; Okamura Y; Kinoshita K; Furukawa T Eur J Cancer; 2021 May; 148():239-250. PubMed ID: 33752134 [TBL] [Abstract][Full Text] [Related]
28. Protocol for functional profiling of patient-derived organoids for precision oncology. Nemati N; Boeck N; Lamberti G; Lisandrelli R; Trajanoski Z STAR Protoc; 2024 Mar; 5(1):102887. PubMed ID: 38367233 [TBL] [Abstract][Full Text] [Related]
29. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer. Arvai KJ; Hsu YH; Lee LA; Jones D PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881 [TBL] [Abstract][Full Text] [Related]
30. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases. Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009 [TBL] [Abstract][Full Text] [Related]
31. Colorectal cancer liver metastases organoids retain characteristics of original tumor and acquire chemotherapy resistance. Buzzelli JN; Ouaret D; Brown G; Allen PD; Muschel RJ Stem Cell Res; 2018 Mar; 27():109-120. PubMed ID: 29414601 [TBL] [Abstract][Full Text] [Related]
32. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines. Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980 [TBL] [Abstract][Full Text] [Related]
33. Multiregion ultra-deep sequencing reveals early intermixing and variable levels of intratumoral heterogeneity in colorectal cancer. Suzuki Y; Ng SB; Chua C; Leow WQ; Chng J; Liu SY; Ramnarayanan K; Gan A; Ho DL; Ten R; Su Y; Lezhava A; Lai JH; Koh D; Lim KH; Tan P; Rozen SG; Tan IB Mol Oncol; 2017 Feb; 11(2):124-139. PubMed ID: 28145097 [TBL] [Abstract][Full Text] [Related]
34. Mesenchymal Stem Cell-derived Extracellular Vesicles Transmitting MicroRNA-34a-5p Suppress Tumorigenesis of Colorectal Cancer Through c-MYC/DNMT3a/PTEN Axis. Zhao J; Lin H; Huang K Mol Neurobiol; 2022 Jan; 59(1):47-60. PubMed ID: 34623601 [TBL] [Abstract][Full Text] [Related]
35. The association between ERK inhibitor sensitivity and molecular characteristics in colorectal cancer. Tayama H; Karasawa H; Yamamura A; Okamura Y; Katsuoka F; Suzuki H; Kajiwara T; Kobayashi M; Hatsuzawa Y; Shiihara M; Bin L; Gazi MY; Sato M; Kumada K; Ito S; Shimada M; Furukawa T; Kamei T; Ohnuma S; Unno M Biochem Biophys Res Commun; 2021 Jun; 560():59-65. PubMed ID: 33989908 [TBL] [Abstract][Full Text] [Related]
36. Modeling Colorectal Cancer Progression Through Orthotopic Implantation of Organoids. de Sousa E Melo F; Harnoss JM; Kljavin N; Scott R; Sohn C; Leong KG; de Sauvage FJ Methods Mol Biol; 2020; 2171():331-346. PubMed ID: 32705654 [TBL] [Abstract][Full Text] [Related]
37. Tumour YAP1 and PTEN expression correlates with tumour-associated myeloid suppressor cell expansion and reduced survival in colorectal cancer. Yang R; Cai TT; Wu XJ; Liu YN; He J; Zhang XS; Ma G; Li J Immunology; 2018 Oct; 155(2):263-272. PubMed ID: 29770434 [TBL] [Abstract][Full Text] [Related]
38. Transcriptomic landscape of sodium butyrate-induced growth inhibition of human colorectal cancer organoids. Li F; Wu Y; Yan Y; Wu S; Zhu J; Zhang G; Zhang P; Yuan L; Zeng Y; Liu Z Mol Omics; 2022 Sep; 18(8):754-764. PubMed ID: 35837877 [TBL] [Abstract][Full Text] [Related]
39. Odontogenic ameloblast-associated protein (ODAM) inhibits human colorectal cancer growth by promoting PTEN elevation and inactivating PI3K/AKT signaling. Yu M; Mu Y; Qi Y; Qin S; Qiu Y; Cui R; Zhong M Biomed Pharmacother; 2016 Dec; 84():601-607. PubMed ID: 27694004 [TBL] [Abstract][Full Text] [Related]
40. Colorectal Cancer Cell Line Proteomes Are Representative of Primary Tumors and Predict Drug Sensitivity. Wang J; Mouradov D; Wang X; Jorissen RN; Chambers MC; Zimmerman LJ; Vasaikar S; Love CG; Li S; Lowes K; Leuchowius KJ; Jousset H; Weinstock J; Yau C; Mariadason J; Shi Z; Ban Y; Chen X; Coffey RJC; Slebos RJC; Burgess AW; Liebler DC; Zhang B; Sieber OM Gastroenterology; 2017 Oct; 153(4):1082-1095. PubMed ID: 28625833 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]